CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Dr. Lalchandani Labs Ltd.

NSE : BSE : 541299 ISIN CODE : INE871Z01013Industry : Hospitals & Medical Services

News

  • Dr. Lalchandani Labs - Letter Of Offer For Rights Issue Of Equity Shares 21 Jan 2026 | 22:52 | Dion Global

    Please find enclosed the soft copy of Letter of Offer dated January 20 2026 for the Rights Issue of Dr Lalchandani Labs Limited. The Company is also ...more...

  • Dr. Lalchandani Labs - Intimation Of Record Date Pursuant To Regulation 42 Of SEBI (Listing Obligations And Disclosure Requir 20 Jan 2026 | 20:46 | Dion Global

    ntimation of Record Date pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 ( Listing Regulations )more...

  • Dr. Lalchandani Labs - Announcement under Regulation 30 (LODR)-Raising of Funds 20 Jan 2026 | 20:42 | Dion Global

    In continuation of our earlier intimation dated December 16 2025 and subsequent deferment notice dated December 22 2025 we wish to inform you that th...more...

  • Dr. Lalchandani Labs - Revised Outcome Of The Board Meeting Held On January 20, 2026 For Approving Terms Of Rights Issue 20 Jan 2026 | 20:39 | Dion Global

    In continuation of our earlier intimation dated December 16 2025 and subsequent deferment notice dated December 22 2025 we wish to inform yo...more...

  • Dr. Lalchandani Labs - Board Meeting Outcome for Outcome Of The Board Meeting Held On January 20, 2026 For Approving Terms Of 20 Jan 2026 | 18:27 | Dion Global

    In continuation of our earlier intimation dated December 16 2025 and subsequent deferment notice dated December 22 2025 we wish to inform you that th...more...

  • Dr. Lalchandani Labs - Intimation Of In-Principle Approval 16 Jan 2026 | 20:56 | Dion Global

    We are pleased to inform that the company has received the In-principle approval from BSE Limited for Rights issue of Equity Shares the lett...more...

  • Dr. Lalchandani Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 12 Jan 2026 | 19:14 | Dion Global

    Compliance Certificate under Regulation 74(5) for Quarter ended December 31 2025more...

  • Dr. Lalchandani Labs - Board Meeting Outcome for Intimation Of Deferment Of Board Meeting Scheduled On December 22, 2025 22 Dec 2025 | 17:29 | Dion Global

    This is with reference to our prior intimation dated December 16 2025 wherein we had informed the Exchange about the meeting of the Board of...more...

  • Dr. Lalchandani Labs - Board Meeting Intimation for Fund Raising 16 Dec 2025 | 17:55 | Dion Global

    Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/12/2025 inter alia to consider a...more...

  • Dr. Lalchandani Labs - Announcement under Regulation 30 (LODR)-Raising of Funds 15 Dec 2025 | 17:21 | Dion Global

    Board of Directors in the Board Meeting held today has approved the raising of fund by way of right issue to the eligible equity shareholder...more...

  • Dr. Lalchandani Labs - Board Meeting Outcome for Outcome Of Board Meeting Held On December 15, 2025 15 Dec 2025 | 17:17 | Dion Global

    Raising of funds through the issuance of equity shares of face value ?10 each by way of rights issue for an amount not exceeding Rs 433.31 Lakhs to t...more...

  • Dr. Lalchandani Labs - Board Meeting Outcome for Outcome Of Board Meeting 09 Dec 2025 | 18:06 | Dion Global

    Outcome of Board Meetingmore...

  • Dr. Lalchandani Labs - Board Meeting Intimation for Considering Of Raising Of Funds Through A Rights Issue And/Or Any Other P 02 Dec 2025 | 15:03 | Dion Global

    Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/12/2025 inter alia to consider a...more...

  • Dr. Lalchandani Labs - Board Meeting Outcome for Unaudited Financial Results For The Half Year Ended September 2025 14 Nov 2025 | 18:32 | Dion Global

    Unaudited Financial Results for the half year ended September 2025more...

  • Dr. Lalchandani Labs - Unaudited Financials Results For The Half Year Ended September 30, 2025 14 Nov 2025 | 18:30 | Dion Global

    Unaudited Financial results September 30 2025more...

  • Dr. Lalchandani Labs - Board Meeting Intimation for Consider And Approve Financial Statements For The Half Year Ended 30.09.2 10 Nov 2025 | 17:27 | Dion Global

    Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to c...more...

  • Dr. Lalchandani Labs has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025 21 Oct 2025 | 19:20 | Dion Global

    As of September 2025 31.15% is owned by Indian Promoters and 68.85% by Public. Top three Promoters holding highest number of shares of Dr. Lalchandan...more...

  • Dr. Lalchandani Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 10 Oct 2025 | 15:36 | Dion Global

    Certificate under Regulation 74(5) SEBI (DP) Regulationmore...

  • Dr. Lalchandani Labs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report 02 Oct 2025 | 12:18 | Dion Global

    Voting results of 08th AGM of the Companymore...

  • Dr. Lalchandani Labs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report 02 Oct 2025 | 12:18 | Dion Global

    Voting results of 08th AGM of the Companymore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex81857.480.39%
NSE Index25175.40.50%
B500DIVL503634.791.21%
BSE 1000 10589.540.47%
BSE 100LCTMC9290.060.58%
BSE Auto 58980.72-0.97%

Commodity

Gold136103-0.08%
Silver2462901.83%
Copper820.15101.12%
Crude Oil64130.66%
Lead192.443.15%
Mentha Oil1067.40.96%
Nickel2480223.38%

Currency

USD/INR 91.62(0.04 %)
GBP/INR 123.62(0.54 %)
EUR/INR 107.62(0.52 %)
JPY/INR 0.58(0.57 %)
CAD/INR 66.13(-0.46 %)
HKD/INR 11.74(-0.04 %)